Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial
about
Screening with urinary dipsticks for reducing morbidity and mortalitySystematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of DiabetesEpidemiology of diabetesA novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adultsNational patterns in diabetes screening: data from the National Health and Nutrition Examination Survey (NHANES) 2005-2012Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, IraqDetecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelinesThe health system and population health implications of large-scale diabetes screening in India: a microsimulation model of alternative approaches.Barriers to the management of Diabetes Mellitus - is there a future role for Laser Doppler Flowmetry?Editorial on the original article entitled "Changes in diabetes-related complications in the United States, 1990-2010" published in the New England Journal of Medicine on April 17, 2014.The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice.Predictors of participation in preventive health examinations in Austria.Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.Detecting Prediabetes and Diabetes: Agreement between Fasting Plasma Glucose and Oral Glucose Tolerance Test in Thai Adults.Diabetes screening intervals based on risk stratification.Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experienceRecommendations on screening for type 2 diabetes in adultsThe Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trialSocial inequalities in prevalence of diagnosed and undiagnosed diabetes and impaired glucose regulation in participants in the Health Surveys for England series.Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabeteScreening for Type II Diabetes Mellitus in the United States: The Present and the FutureMetabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTClinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults.Opportunistic pathology-based screening for diabetes.Patterns of attendance to health checks in a municipality setting: the Danish 'Check Your Health Preventive Program'.Considerations in the design of randomized trials to screen for type 2 diabetes.Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials.Screening for type 2 diabetes: do screen-detected cases fare better?The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010.How can we identify candidates at highest risk--to screen or not to screen?Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.Blood glucose screening among elderly Malaysians: Who to target?Early detection of type 2 diabetes mellitus and screening for retinopathy are associated with reduced prevalence and severity of retinopathy.Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults.Aortic diameter at age 65 in men with newly diagnosed type 2 diabetes.Mortality and cardiovascular disease outcomes among 740 patients with new-onset Type 2 diabetes detected by screening or clinically diagnosed in general practice.Impact of socio-economic position on health and quality of care in adults with Type 2 diabetes in France: the Entred 2007 study.Prevalence and incidence of diabetes mellitus: a nationwide population-based pharmaco-epidemiological study in Sweden.NHS Health Checks--a naked emperor?
P2860
Q24186492-0FD14EB0-A1F0-4870-97A2-2AA15ACBE91EQ26795627-E1210E06-B145-4E54-97B5-EEA8400FEF3DQ28083813-06DD20B2-6A8E-44AC-8020-BFC15A25D416Q28544686-2330AC02-8E15-409C-8023-AAD0ADC351DAQ30881552-2CB07523-EA2E-4557-94C0-9F93CEE76D5BQ33583497-B892F4FF-4AC7-4705-9BEE-9678F16AF13FQ33712222-D3DC7886-2565-4728-82FD-3ED1B3CCB8B8Q34477117-C1190677-08C2-43CF-9C6E-7DC7FA876392Q34574977-8929FDAF-955F-4CB9-A73C-BA7ABE4B58B4Q34658361-D71C0A4C-75A2-42ED-B54C-35F6DDFD17CAQ35030034-E2906718-7006-401B-990E-CC6ED881298FQ35059635-A7B4AEC6-ECE2-4F9B-B3CF-3670A8624E23Q35205975-507652FB-5F06-45F3-B033-022300C4A695Q35978690-05C8FD4B-3861-4704-BA6E-F55AB54D18C3Q36201511-1C19B566-37CF-4CA8-865E-1532A53DE5A5Q36235072-2827E69D-7D64-4052-A60B-DE973B291137Q36338862-846377AD-7010-43B7-83EA-F6CE94A31E53Q36348650-CE69A4CA-56F7-46CE-A82A-DD925C6B4CB4Q36559607-96BDCA51-A198-46C5-9EBD-7C8DCB092035Q36649862-3ED47102-79C9-44FC-B80E-CF5ECF1FC441Q37002876-166F275B-D275-49F2-A2AB-FCB78E33DDC7Q37104278-88873A6E-3139-475B-A41B-E39DE1FDD675Q37154927-E3A9B014-B856-4AB7-8A61-2AC48A15E58EQ37208411-B78015BF-5709-453E-91DF-6C88D7CD0778Q37545369-2AF7AD28-00DF-4260-A051-1A77FAE0D5B1Q38181450-6184872E-B55F-40E0-BE3D-BA39B6BC501CQ38321672-1CE31B24-279C-487E-9AE3-88CFDBC6977BQ38398902-88B81166-C98D-4182-839E-20B5311965B5Q38426346-23575900-B43C-4D88-9E17-7647726652C0Q38884834-F427EA15-8F6A-4B05-A801-980EE0B63825Q38933848-EC619532-9C7B-4859-87FD-C478A6041D58Q40001113-680AFC1F-7782-414E-9CCC-7BB7498C62FDQ40014904-1E2A249C-BF39-4528-8B74-290E509BE4E1Q40074435-F444BCBC-BF2D-4F18-84EA-CA1E74962ADFQ40074446-F9B2472F-18B7-44FD-89BE-3F48288F26A4Q40231298-61BD4601-5672-4BEF-B604-6EDCDBE1EC3FQ40376811-CF9EEB61-3588-4E38-A536-BFAFE213435FQ41056896-E0C6D82E-C7E8-4AB7-B8D6-36D397BFF8BDQ41463458-72877BA6-4D81-41FB-9820-3852B92011C5Q41709920-59612D06-A2EE-407A-8F96-2673508065BA
P2860
Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Screening for type 2 diabetes ...... er-randomised controlled trial
@ast
Screening for type 2 diabetes ...... er-randomised controlled trial
@en
type
label
Screening for type 2 diabetes ...... er-randomised controlled trial
@ast
Screening for type 2 diabetes ...... er-randomised controlled trial
@en
prefLabel
Screening for type 2 diabetes ...... er-randomised controlled trial
@ast
Screening for type 2 diabetes ...... er-randomised controlled trial
@en
P2093
P2860
P50
P1433
P1476
Screening for type 2 diabetes ...... er-randomised controlled trial
@en
P2093
A Toby Prevost
Ann Louise Kinmonth
Justin B Echouffo-Tcheugui
Lincoln A Sargeant
Stephen J Sharp
P2860
P304
P356
10.1016/S0140-6736(12)61422-6
P407
P577
2012-10-04T00:00:00Z